1

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Global Clinical Trials Review, H2, 2015 Now Available at iData Insights Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Global Clinical Trials Review, H2, 2015

Summary GlobalData's clinical trial report, � Clostridium Difficile Infections (Clostridium Difficile Associated Disease)

Global Clinical Trials Review, H2, 2015" provides an overview of Clostridium Difficile Infections (Clostridium Difficile

Associated Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on

Clostridium Difficile Infections (Clostridium Difficile Associated Disease). Report includes an overview of trial numbers

and their average enrollment in top countries conducted across the globe. The report offers coverage of disease

clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also

provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports

are generated using Global Data� s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are

collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials

database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and

helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report

may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The

report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical

trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report

reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The

report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for

unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for

the past three months *Note: Certain sections in the report may be removed or altered based on the availability and

relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with

regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and

cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in

interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted

(terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional

and country level *Note: Certain sections in the report may be removed or altered based on the availability and

relevance of data for the indicated disease.

Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landing-

page.php?id=124168/clostridium-difficile-infections-clostridium-difficile-associated-disease-global-clinical-trials-

review-h2-2015

To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landing-

page.php?id=124168/clostridium-difficile-infections-clostridium-difficile-associated-disease-global-clinical-trials-

review-h2-2015

Table of Contents

Table of Contents

2 List of Tables

3 List of Figures

4 Report Guidance

6 Clinical Trials by Region

7 Clinical Trials and Average Enrollment by Country

8 Top Five Countries Contributing to Clinical Trials in Asia-Pacific

2

10 Top Five Countries Contributing to Clinical Trials in Europe

11 Top Countries Contributing to Clinical Trials in North America

12 Top Countries Contributing to Clinical Trials in Middle East and Africa

13 Top Five Countries Contributing to Clinical Trials in Central and South America

14 Clinical Trials by G7 Countries: Proportion of Clostridium Difficile Infections (Clostridium Difficile Associated

Disease) to Infectious Disease Clinical Trials

15 Clinical Trials by Phase in G7 Countries

16 Clinical Trials in G7 Countries by Trial Status

17 Clinical Trials by E7 Countries: Proportion of Clostridium Difficile Infections (Clostridium Difficile Associated

Disease) to Infectious Disease Clinical Trials 18 Clinical Trials by Phase in E7 Countries

19 Clinical Trials in E7 Countries by Trial Status

20 Clinical Trials by Phase

21 In Progress Trials by Phase

22 Clinical Trials by Trial Status

23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type

26 Prominent Sponsors

27 Top Companies Participating in Clostridium Difficile Infections (Clostridium Difficile Associated Disease)

Therapeutics Clinical Trials

28 Prominent Drugs

29 Latest Clinical Trials News on Clostridium Difficile Infections (Clostridium Difficile Associated Disease)

30 Sep 28, 2015: Synthetic Biologics Initiates SYN-004 Phase 2b Proof-of-Concept Clinical Trial 30 Sep 21, 2015:

Synthetic Biologics Reports First Analysis Demonstrating SYN-004's Ability to Protect the Microbiome from Damage

Caused by IV Antibiotics in a Humanized Pig Model 30 Sep 20, 2015: Pivotal Phase 3 Studies of Bezlotoxumab,

Merck� s Investigational Antitoxin to Prevent Clostridium Difficile Infection Recurrence, Met Primary Endpoint

31 Sep 18, 2015: Summit Therapeutics Presents New Positive Preclinical Data on Novel C. difficile Antibiotic

SMT19969 at ICAAC 2015

32 Sep 10, 2015: Summit Therapeutics Completes Targeted Enrolment for SMT19969 Phase 2 Trial for C. difficile

Infection

33 Jul 28, 2015: Oragenics Reports Positive In Vivo Antibiotic Efficacy Data in Critical Animal Study

33 Jul 21, 2015: MGB Biopharma commences Phase I clinical trial with oral formulation of MGB-BP-3 for the

treatment of multi-resistant Clostridium Difficile infections

34 Clinical Trial Profile Snapshots

35 Appendix

134 Abbreviations

134 Definitions

134 Research Methodology 135 Secondary Research

135 About GlobalData 136 Contact Us 136 Disclaimer

137 Source

3

Read More @ http://www.idatainsights.com/reports-landing-page.php?id=124168/clostridium-difficile-infections-

clostridium-difficile-associated-disease-global-clinical-trials-review-h2-2015

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research

information aggregator and marketing research consulting firm. We conduct both primary and secondary research.

Our work does not end with research it is also involved in distributing reports for different companies . We provide

actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be

a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that

will make a difference to their bottom line.

Contact Us:

iData Insights

Tel: 1-866-237-2965

Web: http://www.idatainsights.com

Email: info@idatainsights.com

About iData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to

provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our

promise to provide results that are essential to the success of your company. We believe that by doing so, we will

earn the trust of our clients for future projects.